Latest filing published 02 May 2019 for Theravance Biopharma, Inc..
Insider track record
No signal scores available.
Peter S. Ringrose: trading record in brief
Filings by Peter S. Ringrose span 2 companies, the busiest being Innoviva, Inc. and Theravance Biopharma, Inc. The record holds 10 filings, for trades running from 27 April 2010 to 30 April 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 May 2019 with a share grant in Theravance Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter S. Ringrose
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,385 shares0Ordinary SharesSEC:0001179110-19-005467:0
- 8,186 shares0Ordinary SharesSEC:0001179110-18-006194:0
- 6,000 shares0Ordinary SharesSEC:0001179110-17-007545:0
- 6,000 shares0Ordinary SharesSEC:0001179110-16-023939:0
- 6,000 shares0Ordinary SharesSEC:0001179110-15-006596:0
- 6,000 shares0Common StockSEC:0001179110-14-009243:0
- 6,000 shares0Common StockSEC:0001179110-13-007290:0
- 6,000 shares0Common StockSEC:0001179110-12-008611:0
- 6,000 shares0Common StockSEC:0001179110-11-007009:0
- 12,000 shares0Common StockSEC:0001179110-10-007518:0
10 of 10 declarations
